Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Facial & Migraine, MSDs, Trauma, Cancer), And Segment Forecasts, 2019 - 2026

Industry Insights

The global pain management devices market size was valued at USD 5.19 billion in 2018 and is expected to register a CAGR of 13.8% over the forecast period (from 2019 to 2026). High prevalence of diabetes coupled with rising geriatric population base is a high impact rendering driver for this market. According to the estimates of the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 366 million in 2011 to 552 million by 2030.

This is expected to increase the product demand to manage the chronic pain. Moreover, growing geriatric population base suffering from and susceptible to various diseases including non-communicable diseases like Cardiovascular Disorders (CVDs), cancer, and diabetes, is likely to boost the demand further.

Moreover, increasing cases of cancer have also led to rise in the demand for these devices to manage the pain caused due to a tumor compressing a nerve and several other factors depending upon the stage of cancer. The therapies given to the patients are also the potential contributor towards the cancer pain. Studies have shown that around 20 to 50% of cancer patients experience acute pain at the time of diagnosis and around 75% complain about pain during the disease progression.

Asia Pacific regional market is estimated to expand at the highest CAGR of more than 15% from 2019 to 2026. This growth is attributed to the increasing demand for these devices in this region as a result of rising need to curb cancer and diabetes-related chronic pain in a cost-effective manner. In addition, rapidly improving healthcare infrastructure in emerging countries, such as India and Japan, is also contributing toward the market growth in this region.

Product Insights

Electrical stimulators, Radiofrequency Ablation (RFA), analgesic infusion, and neurostimulation devices are the key products. Neurostimulation devices segment, which further includes Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), and sacral neurostimulators, led the market in 2018. These devices have wide applications in chronic pain management, which include stimulation of spinal cord, deep brain, sacral nerve, vagus nerve, Gastric Electrical Stimulation (GES), Repetitive Transcranial Magnetic Stimulation (rTMS), and respiratory electrical stimulation.

The neurostimulation devices are more efficient than traditional methods as they show a sustained reduction in pain. Additionally, traditional therapy involves intake of medicines that possess many adverse effects. These factors are expected to contribute to the growth of this segment. On the other hand, RFA devices are expected to witness the highest growth rate over the forecast period owing to their extensive usage for curing various disorders, such as tumors, cardiac diseases, and varicose veins. Radiofrequency ablation for pain management is the most effective treatment as its effect lasts for 6 to 12 months.

Application Insights

The applications of pain management devices are assessed on the basis of products. Cancer, neuropathic pain, facial pain & migraine, musculoskeletal diseases, and trauma are the major applications. The neurostimulation devices have a substantial share in neuropathic pain as SCS yields best results for the treatment of this pain. Moreover, these devices offer benefits, such as customized level of stimulation depending on the activities undertaken by the person in a day.

RFA devices held a significant share in cancer pain management. These devices exert action by high-temperature thermal therapy that induces coagulation necrotic cells by heating tissue to 100°C. This mechanism of RFA equipment helps in killing cancer cells, thereby enabling effective pain management.

Regional Insights

North America led the global market in terms of revenue share in 2018 due to favorable healthcare infrastructure, which facilitated the access to advanced pain management devices. In addition, government initiatives, such as Precision Medicine and Affordable Care Act, coupled with well-planned reimbursement policies contributed to the market growth in North America. Moreover, rising awareness among people and high purchasing parity led to an increased demand for these devices. Asia Pacific is expected to be the fastest-growing regional market during the forecast period owing to increasing government support to improve healthcare infrastructure. Economic developments in countries, such as India and China, with higher disposable incomes are expected to fuel the product demand further.

Pain Management Devices Market Share Insights

Prominent companies in this market include B Braun Melsungen AG; Baxter International, Inc.; Boston Scientific Corp.; Codman and Shurtleff; DJO Global LLC; Pfizer, Inc.; Medtronic Plc; Smiths Medical; St. Jude Medical, Inc.; and Stryker Corp. Key trends witnessed in this market are M&A and strategic alliances to gain competitive edge over others. For instance, in May 2015, St. Jude Medical, Inc. acquired Spinal Modulation, Inc.-a developer of Axium Neurotransmitter system, which targets a neural structure within the spine-to strengthen its product portfolio in pain management devices.

Report Scope

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global pain management devices market report on the basis of product, application, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2026)

  • Electrical Stimulators

    • Transcutaneous Electrical Nerve Stimulators (TENS)

    • Others

  • Radiofrequency Ablation (RFA)

  • Analgesic Infusion Pumps

    • Intrathecal Infusion Pumps

    • External Infusion Pumps

  • Neurostimulation

    • Spinal Cord Stimulators

    • Deep Brain Stimulators

    • Sacral Neurostimulators

• Application Outlook (Revenue, USD Million, 2014 - 2026)

  • Cancer

  • Neuropathic Pain

  • Facial & Migraine

  • Musculoskeletal Disorders (MSDs)

  • Trauma

• Regional Outlook (Revenue, USD Million, 2014 - 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

    • Saudi Arabia